Comparing fast vs standard kidney therapy for heart shock patients on ECMO
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether starting kidney replacement therapy faster or at the usual time improves outcomes for people with severe heart failure (cardiogenic shock) who are on a heart-lung machine (ECMO) and develop sudden kidney injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have severe heart failure (cardiogenic shock) that needs ECMO (a heart-lung machine).
- You developed sudden kidney injury within the first 48 hours of the heart problem.
- Your kidney injury is not from another cause like infection or dehydration.
- You do not have advanced chronic kidney disease or need dialysis already.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving kidney dialysis to patients who are on a heart-lung bypass machine (ECMO). It aims to find which method works better for filtering the blood.
This trial tests a treatment to help remove extra fluid from the body when the heart is too weak to pump effectively. It may help people in intensive care who have fluid buildup and are at risk of kidney problems.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This trial looks at whether starting dialysis-related care early, aimed at improving blood flow to tissues, can help people in the ICU who have sudden kidney failure. It may help reduce problems related to poor tissue circulation, but it is very specific about ICU illness and current treatments.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial studies people who are starting ECMO, a machine that takes over the work of the heart and lungs, to see if a more tailored approach can improve outcomes. If you join, your care may be adjusted based on your specific needs.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.